Tarsus Pharmaceuticals News

Tarsus Pharmaceuticals | 8-K: Current report

Apr 23 08:39 ET

Tarsus Pharmaceuticals | 8-K: Current report

Mar 5 16:16 ET

Tarsus Pharmaceuticals | 8-K: Current report

Mar 1 17:30 ET

Tarsus Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 29 16:40 ET

Tarsus Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 16:31 ET

Tarsus Pharmaceuticals | 8-K: Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements

Feb 27 13:49 ET

Tarsus Pharmaceuticals | 8-K: Current report

Jan 18 00:00 ET

Tarsus Pharmaceuticals | 8-K: Current report

Jan 8 00:00 ET

Tarsus Pharmaceuticals | 8-K: Current report

Dec 11, 2023 09:01 ET

Tarsus Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Nov 9, 2023 16:18 ET

Tarsus Pharmaceuticals | 8-K: Tarsus Reports Third Quarter 2023 Financial Results and Recent Business Achievements

Nov 9, 2023 16:05 ET

Tarsus Pharmaceuticals | 8-K: Tarsus Reports Second Quarter 2023 Financial Results and Recent Business Achievements

Aug 10, 2023 16:07 ET

Tarsus Pharmaceuticals | 8-K: Current report

Aug 2, 2023 16:10 ET

Tarsus Pharmaceuticals | 8-K: Current report

Jul 31, 2023 16:38 ET

Tarsus Pharmaceuticals | 8-K: Current report

Jul 25, 2023 08:47 ET

Tarsus Pharmaceuticals | 8-K: Current report

Jun 27, 2023 16:23 ET

Tarsus Pharmaceuticals | 8-K: Current report

Jun 15, 2023 16:04 ET

Tarsus Pharmaceuticals | 8-K: Tarsus Reports First Quarter 2023 Financial Results and Recent Business Achievements

May 9, 2023 16:07 ET

Tarsus Pharmaceuticals | DEFA14A: Others

Apr 26, 2023 16:06 ET

Tarsus Pharmaceuticals | DEF 14A: Definitive proxy statements

Apr 26, 2023 16:05 ET